BMY Short Interest Spikes as Analysts Split Ahead of Q3 Print
Bristol-Myers Squibb enters the final stretch before its October 29 earnings with a notable shift in the short-selling picture and a fresh analyst downgrade from a prominent house, two signals pointing in opposite…